Viewing StudyNCT02393859



Ignite Creation Date: 2024-05-06 @ 3:53 AM
Last Modification Date: 2024-10-26 @ 11:40 AM
Study NCT ID: NCT02393859
Status: COMPLETED
Last Update Posted: 2024-05-29
First Post: 2015-03-16

Brief Title: Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk HR First Relapse B-precursor Acute Lymphoblastic Leukemia ALL
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Leukemia Acute Lymphoblastic
Keywords:
Name View
ALL View
High-risk first relapse B-precursor ALL View
Precursor Cell Lymphoblastic Leukemia View
Neoplasms View
Lymphoproliferative Disorders View
Immunoproliferative Disorders View
Antibodies Bispecific View